More than 30 human splicing factors have now been defined, and some of them are characterized as either proto-oncogenes, such as SRSF1, SRFS3, DAM1, and PELP1, or tumor suppressors, such as RBM and PRMT6, in breast cancer [52]. This evidence concerns the gene PRMT6 and breast carcinoma.